That's a really fascinating thought. We often hear and talk about "public health" in the US - but also have serious issues with approving "public" health organizations and care providers. It's ironic how we want our private businesses to take care of our public health.
There's lots of work and discussion going on regarding drug resistance.
Funny, I've been to plenty of conferences and talks about it and I've never seen a journalist.
They just want to churn out articles like this one: FIND OUT ABOUT THIS ONE DEADLY BUG THAT NOBODY WANTS TO TALK ABOUT. No surprise they get few responses.
I don't think that's a fair characterization. The linked article is a "Times Insider" article, so an article about the reporting that went into a much longer article. It focuses on the difficulties the reporter had researching the topic, and I don't think that any of it is fear-mongery like your all-caps title.
The article whose reporting this one focuses on [0] is quite long and strikes me as being well-researched, thorough in its explanations, and not over the top in its take on the issue. Sure, there's a little bit of intrigue, but that just makes for interesting reading.
Without a public conversation about resistant bugs, the causes (drug overuse) will never be addressed.